Market Research Future (MRFR)’s latest study reveals that the Global Bone Graft Substitutes Market is expected to expand at 6.52% CAGR during the forecast period 2017 to 2027.
The Global Bone Graft Substitute Market is expected to touch USD 5,031 million at a stellar 6.52% CAGR over the forecast period (2017-2027). Simply put, bone graft is an implantable material that helps in promoting bone healing, osseous reconstruction and bone formation owing to its osteoinductive, osteogenic and osteoconductive properties. Bone graft is used in spinal surgery, sports, trauma plastic and facial surgery. Besides it can be used for filling the voids during absence of bones and structural stability. It is a surgical method to replace a defected or missing bone using bone graft from the body of the patient, another person, animals or cadaver. Bone graft is also used to heal wounds, treat complex fracture and others.
The rising geriatric population has catapulted the orthopedic industry on an upward trajectory. It is likely to fuel demand for bone graft substitutes over the assessment period. Additionally, the growing demand for bone grafts from the dental care industry is expected to boost the proliferation of the market across the next couple of years.
The factors that are responsible for dictating the growth trajectory of the bone graft substitutes market during the projection period are high demand in military medical units, increasing orthopedic problems, rising need for reconstructive orthopedic treatments, etc. However, there are certain restraints in the market, which include the risk of disease transmission in allografts and xenograft, improper fixation and weak bonding, and risk of graft rejection.
To Get Free Sample Report visit https://www.marketresearchfuture.com/sample_request/1195
Key Players for Global Bone Graft Substitutes Market
Leading players profiled in the bone graft substitute market include Institut Straumann AG, Zimmer Biomet, Stryker Corporation, Medtronic plc, Dentsply Sirona, BioHorizons IPH, Inc, Dentium Co., Ltd., and ACE Surgical Supply Company, Inc.
Feb 2019- Sirakoss Ltd received CE mark clearance for its Osteo, the bone graft substitute which is nanosynthetic in nature intended to augment the healing of patients and offer surgeons with an advanced bone fracture solution. Osteo has specially been designed for supporting the skeletal system post corrective surgery of any deformity condition or completing bone regeneration following a fracture. This bone graft material will help in filling gaps in the skeletal system and can be used on its own or in combination with allograft or autograft.
In September 2018, Baxter International Inc., an American healthcare company, announced the receipt of FDA clearance for Actifuse Flow bone graft substitute to be used in orthopedic surgical procedures.
In November 2018, Bio2 Technologies, an orthopedic company, has received approval from FDA for evaluation of its Vitrium bioactive glass as a cervical interbody fusion device. Vitrium is currently in use as a bone graft.
Segments for Global Bone Graft Substitutes Market
Market Research Future report offers an all-inclusive segmental analysis of the bone graft substitute market on the basis type and application.
Based on type, it is segmented into bone morphogenetic protein, synthetic bone grafts, demineralized bone matrix, autograft and others.
Based on application, the bone graft substitute market is segmented into foot and ankle, dental, long bone, joint reconstruction, spinal fusion and others. Of these, spinal fusion is expected to have the maximum share in the market.
Regional Analysis for Global Bone Graft Substitutes Market
Based on region, the bone graft substitute market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will dominate the market and hold its position during the forecast period at a favorable 6.1% CAGR. It is owing to factors such as advancements in technology in healthcare, existence of key players and others. US has a highly developed healthcare sector which is another key reason that is driving the bone graft substitute market in this region. Europe grabs the second largest position and is anticipated to grow at a healthy 6.76% CAGR due to rising awareness regarding bone graft substitutes coupled with increasing healthcare expenditure. The bone graft substitute market in the APAC region is expected to grow at 6.85% CAGR over the forecast period. The existence of fast developing economies like India and China are greatly supporting the market growth. On the other hand, the bone graft substitute market in the Middle East and Africa is anticipated to have a steady growth owing to developments in the Gulf nations’ healthcare sector.
To Get an Exclusive Discount on Report Visit https://www.marketresearchfuture.com/check-discount/1195
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
TOC Continued…
To Browse Complete Report visit https://www.marketresearchfuture.com/reports/bone-graft-substitutes-market-1195
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
